Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differing reverse transcriptase mutation patterns in individuals experiencing viral rebound on first-line regimens with stavudine/didanosine and stavudine/lamivudine.

AIDS (London, England) - 13 Apr 2001

Moyle G J, Gazzard B G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Didanosine
Share to Drug Resistance, Microbial
Share to Drug Resistance, Multiple

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lamivudine

Share to Reverse Transcriptase Inhibitors

Share to RNA-Directed DNA Polymerase

Share to Stavudine

Source

Identifiers

PMID: 11371696
DOI: 10.1097/00002030-200104130-00017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differing reverse transcriptase mutation patterns in individuals experiencing viral rebound on first-line regimens with stavudine/didanosine and stavudine/lamivudine.PMID 11371696Read ↗

Current insights into reverse transcriptase inhibitor-associated resistance.Semantic proximity Read ↗

Different viral rebound following discontinuation of antiretroviral therapy in cases of infection with viruses carrying L74V or thymidine-associated mutations.Semantic proximity Read ↗

Zidovudine resistance reverse transcriptase mutations during didanosine monotherapy.Semantic proximity Read ↗

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.Semantic proximity Read ↗

Antiretroviral Resistance After First-Line Antiretroviral Therapy Failure in Diverse HIV-1 Subtypes in the SECOND-LINE Study.Semantic proximity Read ↗

HIV genotype mutations evoked by nelfinavir-based regimens: frequency, background, and consequences on subsequent treatment options.Semantic proximity Read ↗

HIV-1 re-suppression on a first-line regimen despite the presence of phenotypic drug resistance.Semantic proximity Read ↗

Mutations in the reverse transcriptase gene of HIV type 1 from subjects after stavudine-didanosine dual therapy.Semantic proximity Read ↗

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.Semantic proximity Read ↗

Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa.Semantic proximity Read ↗

Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.Semantic proximity Read ↗

Isolated lopinavir resistance after virological rebound of a ritonavir/lopinavir-based regimen.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.